NATHAN BUELL: Open Payments
NPI 1407586431 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$135 in 6 payments from 4 companies in 2025. Trend: 2023 $224 · 2024 $200 · 2025 $135
Food & beverage: $135
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Medtronic, Inc. | 2 | $45 |
| Boston Scientific Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: LEQVIO, COBALT DR MRI SURESCAN, WATCHMAN FLX, AZURE XT DR MRI SURESCAN, FARXIGA.
Industry payments across IN — which companies pay providers there.
